[Federal Register Volume 66, Number 173 (Thursday, September 6, 2001)]
[Notices]
[Page 46653]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-22326]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on February 9, 2001, Chattam 
Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, 
Tennessee 37409, made application by renewal and by letter dated June 
11, 2001, to the Drug Enforcement Administration (DEA) for registration 
as a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                   Drug                               Schedule
------------------------------------------------------------------------
N-Ethylamphetamine (1475).................  I
4-Methoxyamphetamine (7411)...............  I
2,5-Dimethoxyamphetamine (7396)...........  I
Difenoxim (9168)..........................  I
Amphetamine (1100)........................  II
Methamphetamine (1105)....................  II
Methylphenidate (1724)....................  II
Pentobarbital (2270)......................  II
Secobarbital (2315).......................  II
Codeine (9050)............................  II
Oxycodone (9143)..........................  II
Diphenoxylate (9170)......................  II
Hydrocodone (9193)........................  II
Meperidine (9230).........................  II
Morphine (9300)...........................  II
Thebaine (9333)...........................  II
Alfentanil (9737).........................  II
Sufentanil (9740).........................  II
Fentanyl (9801)...........................  II
------------------------------------------------------------------------

    The firm plans to bulk manufacture the listed controlled substances 
to produce products for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than November 5, 2001.

    Dated: August 24, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-22326 Filed 9-5-01; 8:45 am]
BILLING CODE 4410-09-M